HAM
REGN icon

Highstreet Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Highstreet Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$650K Sell
1,732
-60
-3% -$20.2K 0.03% 206
2019
Q3 		$497K Buy
+1,792
New +$530K 0.02% 202

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Highstreet Asset Management's REGN Position: Q4 2019 in Review

Highstreet Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 3.3% in Q4 2019, selling an estimated $20.2K and leaving 1,732 shares worth $650K. The position accounts for 0.03% of the portfolio, ranked #206.

Highstreet Asset Management first reported a position in REGN in Q3 2019 and has held it in 2 quarters since. 703 funds tracked by Wall St. Rank hold REGN as of Q4 2019.

  • Highstreet Asset Management held 1,732 shares of Regeneron Pharmaceuticals worth $650K as of Q4 2019.
  • Highstreet Asset Management sold 60 Regeneron Pharmaceuticals shares in Q4 2019, an estimated $20.2K.
  • Regeneron Pharmaceuticals made up 0.03% of Highstreet Asset Management's portfolio in Q4 2019, its #206 holding.
  • Highstreet Asset Management first reported a position in Regeneron Pharmaceuticals in Q3 2019 and has held it in 2 quarters since.
  • 703 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2019.

Based on Highstreet Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.